about
Inhibition of TBK1 attenuates radiation-induced epithelial-mesenchymal transition of A549 human lung cancer cells via activation of GSK-3β and repression of ZEB1Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor modelIL-6 receptor is a possible target against growth of metastasized lung tumor cells in the brain.Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma.The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer.Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.Efficacy assessment of pemetrexed treatment of an NSCLC case with brain metastasis.Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors.Brain metastases epidemiology in a Tunisian population: trends and outcome.Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure.Prognosis for non-small cell lung cancer patients with brain metastases.Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer
P2860
Q28306715-504C7935-2089-46DF-A769-E4EEE5FDAF85Q35053858-F368AB13-91B5-478B-9783-89A982B8BE51Q36524188-B3FB87FE-3C17-41B0-812B-EECDC1BEC4ABQ36562978-63B1892C-52E4-4B92-A791-857D2A0F5F41Q36589929-98096728-3B3B-421A-B924-269C923DB8C9Q37231062-7DC40EBF-5882-4477-B0D8-AC4C82EBB9D8Q37551937-41B64A4A-26D5-49DC-9FB5-423BB59E6437Q37642541-7416FAAA-9F68-41E3-84D3-76EFA1E3EEC0Q41115642-E85F5639-AC68-4252-9AC1-1B811A4B163EQ46108334-3E06887F-AC76-4B4E-9D12-D8B906D74233Q47853592-C4096D7E-126D-4214-96F4-8A3802632122Q48683270-E31DDFC8-C5EE-4C42-A491-3E654E75CEF6Q50050567-EECA80C0-BE52-41CE-84AC-E8B849531FC8Q58733006-12C63256-1C50-4278-8363-1D126B9E8D74
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Treatment of brain metastasis from lung cancer.
@ast
Treatment of brain metastasis from lung cancer.
@en
Treatment of brain metastasis from lung cancer.
@nl
type
label
Treatment of brain metastasis from lung cancer.
@ast
Treatment of brain metastasis from lung cancer.
@en
Treatment of brain metastasis from lung cancer.
@nl
prefLabel
Treatment of brain metastasis from lung cancer.
@ast
Treatment of brain metastasis from lung cancer.
@en
Treatment of brain metastasis from lung cancer.
@nl
P2093
P356
P1476
Treatment of brain metastasis from lung cancer.
@en
P2093
Bierta E Barfod
Dong Gyu Kim
Ji Hoon Phi
Masaaki Yamamoto
Takuya Kawabe
Yoichi Urakawa
P304
P356
10.1159/000331188
P577
2012-01-06T00:00:00Z